Propylthiouracil Tablet
Product Images NDC 67253-651

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Propylthiouracil (NDC 67253-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Propylthiouracil Structural Formula (Propylthiouracil Tab 1)

The given text "Molecular Weight: 170.23" suggests that it represents the molecular weight of a chemical compound. The rest of the text, "T CrHighz08", is not readable and cannot provide any useful information.*

FDA Label Image

Principle Display Panel (Propylthiouracil Tab 2)

This is a description of a medication with the NDC code 67253-651-11. Each tablet contains Propylthiouracil, USP at a strength of 50 mg. This medication is indicated for the treatment of hyperthyroidism. The adult dosage is not given in the description. The medication is to be dispensed in a well-closed container and stored at a controlled room temperature between 15-30°C (59-86°F). The package contains 1000 tablets and is not intended for household dispensing. The medication is manufactured by Chartwell Pharmaceuticals and distributed by Par Pharmaceutical.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.